Cargando…

Correction to: A systematic comparison of copy number alterations in four types of female cancer

Detalles Bibliográficos
Autores principales:	Kaveh, Fatemeh, Baumbusch, Lars O., Nebdal, Daniel, Børresen-Dale, Anne-Lise, Lingjærde, Ole Christian, Edvardsen, Hege, Kristensen, Vessela N., Solvang, Hiroko K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769487/ https://www.ncbi.nlm.nih.gov/pubmed/29338700 http://dx.doi.org/10.1186/s12885-017-3766-7

Ejemplares similares

A systematic comparison of copy number alterations in four types of female cancer
por: Kaveh, Fatemeh, et al.
Publicado: (2016)

Linear and non-linear dependencies between copy number aberrations and mRNA expression reveal distinct molecular pathways in breast cancer
por: Solvang, Hiroko K, et al.
Publicado: (2011)

Allele-specific disparity in breast cancer
por: Kaveh, Fatemeh, et al.
Publicado: (2011)

Canine Mammary Tumours Are Affected by Frequent Copy Number Aberrations, including Amplification of MYC and Loss of PTEN
por: Borge, Kaja S., et al.
Publicado: (2015)

Identifying In-Trans Process Associated Genes in Breast Cancer by Integrated Analysis of Copy Number and Expression Data
por: Aure, Miriam Ragle, et al.
Publicado: (2013)

Copynumber: Efficient algorithms for single- and multi-track copy number segmentation
por: Nilsen, Gro, et al.
Publicado: (2012)

Comparison of the Agilent, ROMA/NimbleGen and Illumina platforms for classification of copy number alterations in human breast tumors
por: Baumbusch, LO, et al.
Publicado: (2008)

Quantitative DNA methylation analyses reveal stage dependent DNA methylation and association to clinico-pathological factors in breast tumors
por: Klajic, Jovana, et al.
Publicado: (2013)

DNA copy number motifs are strong and independent predictors of survival in breast cancer
por: Pladsen, Arne V., et al.
Publicado: (2020)

miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer
por: Lindholm, Evita Maria, et al.
Publicado: (2019)

DNA methylation and gene expression patterns in breast cancer progression from in situ carcinoma to invasive carcinoma
por: Fleischer, Thomas, et al.
Publicado: (2013)

Individual and combined effects of DNA methylation and copy number alterations on miRNA expression in breast tumors
por: Aure, Miriam Ragle, et al.
Publicado: (2013)

Systematic assessment of prognostic gene signatures for breast cancer shows distinct influence of time and ER status
por: Zhao, Xi, et al.
Publicado: (2014)

Linkage disequilibrium pattern of the ATM gene in breast cancer patients and controls; association of SNPs and haplotypes to radio-sensitivity and post-lumpectomy local recurrence
por: Edvardsen, Hege, et al.
Publicado: (2007)

Mutations for the people
por: Kristensen, Vessela, et al.
Publicado: (2010)

The multitude of molecular analyses in cancer: the opening of Pandora’s box
por: Russnes, Hege G, et al.
Publicado: (2014)

Differential DNA methylation analysis of breast cancer reveals the impact of immune signaling in radiation therapy
por: Halvorsen, Ann Rita, et al.
Publicado: (2014)

ATM variants and cancer risk in breast cancer patients from Southern Finland
por: Tommiska, Johanna, et al.
Publicado: (2006)

Intratumor heterogeneity defines treatment‐resistant HER2+ breast tumors
por: Rye, Inga H., et al.
Publicado: (2018)

Expression levels of uridine 5'-diphospho-glucuronosyltransferase genes in breast tissue from healthy women are associated with mammographic density
por: Haakensen, Vilde D, et al.
Publicado: (2010)

Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF
por: Tinholt, Mari, et al.
Publicado: (2015)

Mapping the location of recurring amplicons in array-CGH data
por: Lingjærde, OC, et al.
Publicado: (2005)

Combining Gene Signatures Improves Prediction of Breast Cancer Survival
por: Zhao, Xi, et al.
Publicado: (2011)

Cis-regulatory mutations associate with transcriptional and post-transcriptional deregulation of gene regulatory programs in cancers
por: Castro-Mondragon, Jaime A, et al.
Publicado: (2022)

Multilocus analysis of SNP and metabolic data within a given pathway
por: Kristensen, Vessela N, et al.
Publicado: (2006)

DNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment response
por: Dejeux, Emelyne, et al.
Publicado: (2010)

Whole genome copy number analyses reveal a highly aberrant genome in TP53 mutant lung adenocarcinoma tumors
por: Bjaanæs, Maria Moksnes, et al.
Publicado: (2021)

Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer
por: Muggerud, Aslaug Aa, et al.
Publicado: (2010)

Basal-like Breast cancer DNA copy number losses identify genes involved in genomic instability, response to therapy, and patient survival
por: Weigman, Victor J., et al.
Publicado: (2011)

Gene expression analyses in breast cancer epidemiology: the Norwegian Women and Cancer postgenome cohort study
por: Dumeaux, Vanessa, et al.
Publicado: (2008)

Genome‐wide DNA methylation analyses in lung adenocarcinomas: Association with EGFR, KRAS and TP53 mutation status, gene expression and prognosis
por: Bjaanæs, Maria Moksnes, et al.
Publicado: (2015)

Long Non-Coding RNAs Differentially Expressed between Normal versus Primary Breast Tumor Tissues Disclose Converse Changes to Breast Cancer-Related Protein-Coding Genes
por: Reiche, Kristin, et al.
Publicado: (2014)

Gefitinib in Combination with Weekly Docetaxel in Patients with Metastatic Breast Cancer Caused Unexpected Toxicity: Results from a Randomized Phase II Clinical Trial
por: Engebraaten, Olav, et al.
Publicado: (2012)

Copy number variations alter methylation and parallel IGF2 overexpression in adrenal tumors
por: Nielsen, Helene Myrtue, et al.
Publicado: (2015)

Overrepresentation of transcription factor families in the genesets underlying breast cancer subtypes
por: Joshi, Himanshu, et al.
Publicado: (2012)

High Levels of Genomic Aberrations in Serous Ovarian Cancers Are Associated with Better Survival
por: Baumbusch, Lars O., et al.
Publicado: (2013)

Intratumoural mRNA expression of genes from the oestradiol metabolic pathway and clinical and histopathological parameters of breast cancer
por: Yoshimura, Noriko, et al.
Publicado: (2004)

NOTCH2 in breast cancer: association of SNP rs11249433 with gene expression in ER-positive breast tumors without TP53 mutations
por: Fu, Yi-Ping, et al.
Publicado: (2010)

Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis
por: Fleischer, Thomas, et al.
Publicado: (2014)

Gene expression analysis supports tumor threshold over 2.0 cm for T-category breast cancer
por: Solvang, Hiroko K., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_b16vgbcso76aph8g0v9kaim9nn